超声引导热消融治疗T1b及选择性T2甲状腺乳头状癌:证据、指南推荐与超声工作流程
本文综述了热消融治疗T1b及选择性T2甲状腺乳头状癌的现有证据与指南推荐。T1b研究显示局部控制良好且永久性并发症低,但证据为回顾性、地域集中且异质,手术仍是参考治疗。四项T2回顾性报告提示操作安全边际更窄,肿瘤越大符合肿瘤学和技术要求的患者越少。
要点
- T1b热消融局部控制良好、永久并发症低,但证据级别有限,手术仍为参考治疗。
- T2热消融操作安全边际更窄,需严格选择患者。
- T1a、T1b、T2采用相同解剖选择标准,但肿瘤增大时符合条件者减少。
诊断标准与关键数值
- T1b研究提示局部控制良好且永久性并发症低,但证据为回顾性、地域集中且异质。
- 四项T2回顾性报告提示操作安全边际更窄。
- T1a、T1b和T2疾病采用相同的解剖选择标准。
临床应用与阅片要点
- T1b热消融可作为手术之外的选项,但需告知证据局限性。
- T2热消融应严格评估解剖条件和肿瘤学要求,注意安全边际更窄。
- 肿瘤越大,符合肿瘤学和技术要求的患者越少,需警惕分期或切缘不完整。
局限性
- T1b证据为回顾性、地域集中且异质。
- T2证据仅来自四项回顾性报告。
英文原文(摘要)· 点击展开
Ultrasonography. 2026 Nov;45(6):529-548. doi: 10.14366/usg.26199. Epub 2026 Oct 27. ABSTRACT Thermal ablation (TA) is established for benign thyroid nodules, recurrent thyroid carcinoma, and low-risk papillary thyroid microcarcinoma. Its role in papillary thyroid carcinoma (PTC) remains unsettled. This review examines evidence and guideline recommendations for TA in T1b and selected T2 PTC. T1b studies suggest encouraging local control and low permanent morbidity, but retrospective, geographically concentrated, heterogeneous evidence leaves surgery as the reference treatment. Four retrospective T2 reports indicate a narrower procedural safety margin. The same anatomical selection criteria apply across T1a, T1b, and T2 disease; however, as tumors enlarge, fewer patients meet oncological and technical requirements, and incomplete staging or margins have greater consequences. PMID: 42958856 | DOI: 10.14366/usg.26199
引用
- 指南共识 · 介入放射:Ultrasound-guided thermal ablation for T1b and selected T2 papillary thyroid carcinoma: current evidence, evolving guideline recommendations, and an ultrasound-based clinical workflow
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。